Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $209.27 million as of April 25, 2024. Its market cap has decreased by -11.51% in one year.

• Market Cap: 209.27M
• Enterprise Value: 176.73M
• 1-Year Change: -11.51%
• Ranking: #3602
• Category: Micro-Cap
• Stock Price: $1.11

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $209.27M, an increase of 41.98%. That is a compound annual growth rate of 1.39%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	207.40M	-3.49%
Apr 23, 2024	214.90M	-
Apr 22, 2024	214.90M	-0.88%
Apr 19, 2024	216.80M	-4.16%
Apr 18, 2024	226.20M	-6.99%
Apr 17, 2024	243.20M	12.18%
Apr 16, 2024	216.80M	-8.02%
Apr 15, 2024	235.70M	-3.84%
Apr 12, 2024	245.10M	-7.79%
Apr 11, 2024	265.80M	4.44%
Apr 10, 2024	254.50M	-3.56%
Apr 9, 2024	263.90M	-4.76%
Apr 8, 2024	277.10M	5.00%
Apr 5, 2024	263.90M	-2.80%
Apr 4, 2024	271.50M	5.89%
Apr 3, 2024	256.40M	-2.84%
Apr 2, 2024	263.90M	-4.14%
Apr 1, 2024	275.30M	-1.33%
Mar 28, 2024	279.00M	5.72%
Mar 27, 2024	263.90M	6.84%
Mar 26, 2024	247.00M	2.36%
Mar 25, 2024	241.30M	0.79%
Mar 22, 2024	239.40M	-6.63%
Mar 21, 2024	256.40M	11.48%
Mar 20, 2024	230.00M	0.83%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
ChromaDex	222.16M
AVITA Medical	219.79M
Design Therapeutics	217.85M
Accuray	215.20M
Foghorn Therapeutics	214.96M
Merrimack Pharmaceuticals	214.05M
G1 Therapeutics	214.02M
Senseonics Holdings	211.63M